Document is current

Article History

Received: 16 April 2025

Accepted: 15 August 2025

First Online: 1 September 2025

Declarations

:

: All cell lines were cultured in the conditions recommended by the manufacturers and collaborators, and only used for research purposes specifically described in this research article. All the animal experiments were kept to the National Regulation of China for Care and Use of Laboratory Animals. Both female BALB/c mice and female C57BL/6 mice were purchased from Beijing Huafukang Biotech Co., Ltd. (Beijing, China). The mice were housed in a ventilated, temperature-controlled, and illumination-controlled animal facility without specific pathogen (20 ± 2 °C; 50% ± 10%; illumination, 8:00–20:00; dark, 20:00–8:00).

: All the authors read and approved the final version of the manuscript.

: All authors were employed by Beijing Youcare Kechuang Pharmaceutical Technology Co. Ltd. G.S. and H.Z. are inventors on a pending patent related to this work filed by Beijing Youcare Kechuang Pharmaceutical Technology Co. Ltd.